Robustly interrogating machine learning-based scoring functions: what are they learning?
Durant G. et al, (2025), Bioinformatics
Fragmenstein: predicting protein-ligand structures of compounds derived from known crystallographic fragment hits using a strict conserved-binding-based methodology.
Ferla MP. et al, (2025), J Cheminform, 17
EEFSEC deficiency: A selenopathy with early-onset neurodegeneration.
Laugwitz L. et al, (2025), Am J Hum Genet, 112, 168 - 180
Toward target 2035: EUbOPEN - a public-private partnership to enable & unlock biology in the open.
Tredup C. et al, (2024), RSC Med Chem
A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel disease.
Thomas T. et al, (2024), Nat Immunol, 25, 2152 - 2165
A data science roadmap for open science organizations engaged in early-stage drug discovery.
Edfeldt K. et al, (2024), Nat Commun, 15
Improving the representativeness of UK’s national COVID-19 Infection Survey through spatio-temporal regression and post-stratification
POUWELS K. et al, (2024), Nature Communications
Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population
Jia W. et al, (2024), Nature Communications
Enabling equitable and affordable access to novel therapeutics for pandemic preparedness and response via creative intellectual property agreements.
Griffen EJ. et al, (2024), Wellcome Open Res, 9
Robustly interrogating machine learning-based scoring functions: what are they learning?
Durant G. et al, (2023)
Venus: Elucidating the impact of amino acid variants on protein function beyond structure destabilisation
Ferla M. et al, (2023), EUROPEAN JOURNAL OF HUMAN GENETICS, 31, 614 - 614
Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
Writing Committee for the REMAP-CAP Investigators None. et al, (2021), JAMA
Antibodies to SARS-CoV-2 are associated with protection against reinfection
Lumley SF. et al, (2020)